http://hdl.handle.net/1765/16438
isbn: 978-908559-244-0

Staging Investigations in Patients with Esophageal Cancer: A Critical Re-Appraisal

(Stadiëringsonderzoeken bij patiënten met slokdarmkanker: een kritische beoordeling)


Doctoral Thesis
Published by
Related Files
asset icon
(061222_Vliet, Evelyn Petronella Margaretha van.pdf, 0.7MB)
asset icon
(Stellingen Vliet, Evelyn Petronella Margaretha van.pdf, 0.0MB)
asset icon
(Evelyn van Vliet cover.pdf, 0.0MB)

The incidence of esophageal cancer has been increased over the years. In 1989, the incidence was 6.9 cases of esophageal cancer per 100,000 men and 2.4 cases per 100,000 women in The Netherlands. In 2003, the incidence had increased to 11.9 cases per 100,000 men and 3.8 cases per 100,000 women. Currently, about 1,400 patients are annually diagnosed with esophageal cancer in The Netherlands (1). The two major types of esophageal cancer are squamous cell carcinoma and adenocarcinoma, which comprises more than 90% of esophageal cancer cases. Complaints, such as weight loss, dysphagia or pain, usually arise in an advanced stage of the disease. As a consequence, more than 50% of patients have already locally advanced cancer, lymph node metastases, or distant metastases at the time of presentation (2). The 5-year survival rate for esophageal cancer is low, i.e., 10-15% (3).


Supervisor (promotor):

Prof. Dr. Kuipers, E.J.

The author wishes to thank:

AstraZeneca B.V.,
Janssen-Cilag B.V.,
Medicor,
Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam,
Boston Scientifi c B.V.,
Novartis Oncology,
Tramedico B.V.,
Pentax Nederland B.V.


Keywords


Automatically Extracted Terms
  • patient
  • esophageal
  • cancer
  • center
  • metastase
  • lymph
  • esophageal cancer
  • result
  • stage
  • lymph nodes
  • carcinoma
  • ct scans
  • study
  • investigation
  • cardia cancer
  • referral center
  • esophageal carcinoma
  • sensitivity
  • accuracy
  • preoperative


Bookmark with: